Research Study

Effects of Enteral Glutamine Supplementation on Mortality and Infectious Morbidity in Severely Burned Patients: a Multi-center Pilot Trial
Principal Investigator 
William Henderson

Overview

Body Locations and Systems 
Skin Conditions
Diagnosis and Therapy 
Critical Care
ClinicalTrials.gov# 
NCT00985205
Status 
Recruiting
Study Start/End 
Feb 19, 2016 to Dec 31, 2019
Locations 
Vancouver General Hospital
Name/Title 
Denise A. Foster, Research Coordinator
Phone 
604-875-4111 ext.68336
Email Address 
denise.foster@vch.ca
Purpose of Study 

The purpose of this study is to test the following hypotheses:

  • Enteral glutamine administration decreases in-hospital mortality in adult subjects with severe thermal burn injuries.
  • Enteral glutamine administration decreases infectious morbidity and shortens length of care in adult subjects with severe thermal burn injuries.
  • Enteral glutamine administration decreases the cost of care of adult subjects with severe thermal burn injuries.

The objectives of this proposed pilot trial relate to evaluating the feasibility of the study protocol. Specifically, the investigators want to assess the following outcomes in a sample of 200 patients in 8 sites:

  • Number of patients enrolled per site per month and reasons for non-enrollment.
  • Rate of consent for eligible patients.
  • Rate of adherence to study interventions and reasons for non-adherence
Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.